Export

EN
FR
Anti-tetanus immunoglobulin
Essential medicine status
Section:
11. Blood products of human origin and plasma substitutes 11.2. Plasma-derived medicines 11.2.1. Human immunoglobulins
ATC codes: J06BB02
EMLc
Indication
Tetanus ICD11 code: 1C13
Medicine type
Biological agent
List type
Core (EML)
(EMLc)
Additional notes
All human plasma-derived medicines should comply with the WHO requirements
Formulations
Parenteral > General injections > IM: 500 IU in vial
EML status history
First added in 1984 (TRS 722)
Changed in 1989 (TRS 796)
Changed in 1991 (TRS 825)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Tags
Wikipedia
Anti-tetanus immunoglobulin
DrugBank
Anti-tetanus immunoglobulin (Tetanus Immune Globulin)
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended that immunoglobulins of human origin currently listed in Section 19.2 Sera and immunoglobulins, should be transferred to Section 11.2.1 Human immunoglobulins.